Значение20202021202220232024TTMДенежный поток от инвестиционной деятельности-156.79 K-47.72 K-134.26 K-48.95 K-20.65 K-27.61 KДенежный поток от финансовой деятельности12.51 M12.78 M35.35 M4.06 M23.75 M20.71 MСвободный денежный поток-2.91 M-11.24 M-19.16 M-25.22 M-24.7 M-24.29 M
GeoVax Labs Inc
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated.